Irvine, CA, United States of America

Thomas L Poulos

This inventor holds 3 USPTO granted patents. Top assignees: University of California, Northwestern University. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas L Poulos. Retrieved from https://idiyas.com/inventor/thomas-l-poulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2006-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas L Poulos: Innovator in Melanoma Treatment

Introduction

Thomas L Poulos is a notable inventor based in Irvine, CA, who has made significant contributions to the field of melanoma treatment. With a total of 3 patents, his work focuses on innovative therapies aimed at combating this serious form of skin cancer.

Latest Patents

Poulos's latest patents include "Specific nNOS inhibitors for the therapy and prevention of human melanoma" and "Inhibitors of nitric oxide synthase for treatment of melanoma." These patents detail methods for melanoma treatment and prevention using selective nitric oxide synthase inhibitor compounds, either alone or in conjunction with other therapies.

Career Highlights

Throughout his career, Thomas L Poulos has worked with prestigious institutions such as the University of California and Northwestern University. His research has been pivotal in advancing the understanding and treatment of melanoma.

Collaborations

Poulos has collaborated with esteemed colleagues, including Richard B Silverman and Frank L Meyskens, further enhancing the impact of his work in the field.

Conclusion

Thomas L Poulos stands out as an influential inventor whose innovative approaches to melanoma treatment continue to shape the landscape of cancer therapy. His contributions are vital in the ongoing fight against melanoma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…